High levels of factor IX increase the risk of venous thrombosis.
about
Hereditary thrombophiliaFactor XI as a target for antithrombotic therapyAcute cardiovascular effects of firefighting and active cooling during rehabilitationInflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study.Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms.Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study.Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia.Thrombin generation profiles in deep venous thrombosis.The plasma hemostatic proteome: thrombin generation in healthy individuals.Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner.A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.Empirical and theoretical phenotypic discrimination.The role of hyperthyroidism as the predisposing factor for superior sagittal sinus thrombosis.Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats.Association of IL-4 gene VNTR variant with deep venous thrombosis in Behçet's disease and its effect on ocular involvementThe cost-benefit ratio of screening pregnant women for thrombophilia.A novel one-step purification of mouse factor IX.F9 Malmö, factor IX and deep vein thrombosis.Update on the physiology and pathology of factor IX activation by factor XIa.Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism EtiologyProphylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice.The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.Recurrent Cerebral Venous Thrombosis Associated with Elevated Factor VIIIEpidemiology of venous thromboembolism.The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice.Massive exploration of perturbed conditions of the blood coagulation cascade through GPU parallelization.An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.Factor IX and deep vein thrombosis.Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX.Emerging therapies for hemophilia: controversies and unanswered questions.Anomalous coagulation factors in non-arteritic anterior ischemic optic neuropathy with central retinal vein occlusion: A case report.Flow-simulated thrombin generation profiles as a predictor of thrombotic risk among pre-menopausal women.Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomicsIn silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus
P2860
Q21093254-954B583F-5303-4021-AC91-7B3363035E3AQ26865486-0C67245C-CA11-4D0A-B2B7-1EB278E990E7Q28390777-575D15ED-54CC-4389-A266-EDD95150AB03Q33255316-A55885C1-5B52-4A6F-84ED-D3345D82334CQ33610908-DAD10786-32FD-44B4-A80C-12C7820B4EB4Q33833259-2F7AFB31-1FEC-4699-BD27-14535DDF56D7Q34144305-5D85938F-C095-4AEB-B94D-F3125A2C6B1FQ34469944-CEFA2A6C-9FC7-4597-88D2-F9BEA3CA7370Q34481022-2C4EBBD5-FBF5-4B3B-92A7-277F9D00FABDQ35200296-E6CB519C-CA79-4372-8D64-923800DCA3CEQ35804461-0C6C0980-2A80-48EC-80E0-AD9B02B08014Q36090193-F873516C-69C9-430C-947B-B5F98E01BBCBQ36377598-72215D56-76A8-4608-A8B9-9789D9AE18DCQ36470216-93C009A3-0A7E-44AF-9C10-298786FD69CCQ36727750-09202CEF-337B-4A71-945F-F5586C252901Q36969463-1D4B54DB-A346-4A26-9823-85DA005A3D5EQ37031645-E35E0505-1EFA-4ACC-B31A-757287DA1F7BQ37175602-D5EE70DA-9830-4C21-B285-6EA288F215CDQ37318613-1932E3F7-FF5E-4E56-87A8-9A5850431ADFQ37373003-1F40A8EC-70AD-46F6-AD17-2E6DD6D54B74Q37623821-604452C4-07B6-46BB-B80B-193AD6DEEA14Q38956551-43680AC2-487B-44EE-8756-6685B9272118Q40028976-ADE5295E-63D6-48C4-88F7-9A9C3B381C30Q41667853-DD00D314-F33A-47ED-89BC-EC90FB00BA9BQ41863794-F10F40B4-7D47-4BD6-9020-8EAD8D1C1BF6Q42213727-E2AA54F3-9CF3-4E0F-A616-416551380696Q42565179-C2D73C07-EBC0-428C-A070-1399162C8295Q43137283-2B0B09BD-0A6E-4F71-8BEA-EC8FAC35B313Q45874429-9B4BD547-8C70-4EF3-B6A3-1AC199219B8BQ50190209-E1A22A64-1ECE-45D9-B4FC-8FF9B9258F01Q50324804-0FE9DEEE-6F01-4178-82E4-48508AF5BFD4Q53073385-7143F206-B721-4AB8-8BC6-3167E2A211E0Q54958581-7E20DEE0-9534-4F20-8E6C-6E5739526312Q55083546-4AA72C85-50D1-43A9-AA89-76DB553A9FE6Q55547491-6EB7A483-DD5D-4AF0-B5B7-AA6A80175EBAQ57165119-DDBE39EB-C333-4EEB-AA92-031DC9F918A0Q57822378-12BD5713-008C-4DA9-841D-55173FFAF002
P2860
High levels of factor IX increase the risk of venous thrombosis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
High levels of factor IX increase the risk of venous thrombosis.
@en
High levels of factor IX increase the risk of venous thrombosis.
@nl
type
label
High levels of factor IX increase the risk of venous thrombosis.
@en
High levels of factor IX increase the risk of venous thrombosis.
@nl
prefLabel
High levels of factor IX increase the risk of venous thrombosis.
@en
High levels of factor IX increase the risk of venous thrombosis.
@nl
P2093
P1433
P1476
High levels of factor IX increase the risk of venous thrombosis.
@en
P2093
Bertina RM
Rosendaal FR
van Hylckama Vlieg A
van der Linden IK
P304
P407
P577
2000-06-01T00:00:00Z